Niagen Bioscience (NAGE) Tax Provisions (2016 - 2026)
Niagen Bioscience (NAGE) posted quarterly Tax Provisions of $417000.0 for Q1 2026, up 148.21% year-over-year from $168000.0 in Q1 2025, and up 42.81% quarter-over-quarter from $292000.0 in Q4 2025.
Niagen Bioscience (NAGE) Tax Provisions (2016 - 2026) Analysis & Trends
Niagen Bioscience (NAGE) has reported Tax Provisions for 4 consecutive years, with $417000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Tax Provisions rose 148.21% year-over-year to $417000.0; the TTM figure through Mar 2026 stood at $1.1 million (up 123.89% YoY), while the FY2025 annual figure was $810000.0, up 165.57% from the prior year.
- Tax Provisions grew to $417000.0 in Q1 2026 per NAGE's latest filing, from $292000.0 in the prior quarter.
- Across five years, Tax Provisions topped out at $417000.0 in Q1 2026 and bottomed at $128000.0 in Q2 2025.
- Historically, Tax Provisions has averaged $255333.3 across 3 years, with a median of $257000.0 in 2025.
- Annual changes were most pronounced in 2025 — Tax Provisions retreated 4.26% — and 2026, when it surged 148.21%.
- Niagen Bioscience's Tax Provisions stood at $305000.0 in 2024, then declined by 4.26% to $292000.0 in 2025, then surged by 42.81% to $417000.0 in 2026.
- Business Quant data shows NAGE's Tax Provisions at $417000.0 in Q1 2026, $292000.0 in Q4 2025, and $222000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 292.00 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 230.90 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 59.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 75.45 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 267.73 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 13.31 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 1.90 Mn |
| 10 | Niagen Bioscience | 238.30 Mn | 171.56 Mn | 19.31 Mn | 106,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 106,000.00 |
| Mar 31, 2026 | 417,000.00 |
| Dec 31, 2025 | 292,000.00 |
| Sep 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 128,000.00 |
| Mar 31, 2025 | 168,000.00 |
| Dec 31, 2024 | 305,000.00 |
| Dec 31, 2016 | 3,500.00 |
| Oct 1, 2016 | 3,153.00 |
| Jul 2, 2016 | 4,087.00 |
| Apr 2, 2016 | -10,740.00 |
| Jan 2, 2016 | 4,527.00 |